Limited usefulness of serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for gastrointestinal and whole-body cancer screening | Scientific Reports
New Technologies Bloom Together for Bettering Cancer Drug Conjugates | Pharmacological Reviews
Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics
Cancers | Free Full-Text | Prognostic and Predictive Molecular Markers in Cholangiocarcinoma
Frontiers | Review of Prognostic Expression Markers for Clear Cell Renal Cell Carcinoma
Elevated tumor markers for monitoring tumor response to immunotherapy - eClinicalMedicine
Prognostic significance of pre- and post-operative tumour markers for patients with gastric cancer | British Journal of Cancer
Clinical significance and diagnostic value of serum NSE, CEA, CA19‑9, CA125 and CA242 levels in colorectal cancer
Cancer biomarker - Wikipedia
Carbohydrate antigen 19-9 — tumor marker: Past, present, and future
Tumor markers in cancer diagnosis and prognosis
Diagnostics | Free Full-Text | The Potential Role of MUC16 (CA125) Biomarker in Lung Cancer: A Magic Biomarker but with Adversity
CA 72-4 marker: adjunct to conventional biomarkers in monitoring of pancreatic, ovarian and colorectal cancers. - Advanced ImmunoChemical Inc.Advanced ImmunoChemical Inc.
Cancer Tumor Markers - ELISA Blood Test Kits
Tissue architecture in tumor initiation and progression: Trends in Cancer
The distribution of tumour marker parameters | Download Table
Trajectories of Perioperative Serum Tumor Markers and Colorectal Cancer Outcomes: A Retrospective, Multicenter Longitudinal Cohort Study - eBioMedicine
Comparison between CEA, CA 19-9 and CA 72-4 in Patients with Colon Cancer
Diseases | Free Full-Text | Diagnostic and Prognostic Value of CEA and CA19-9 in Colorectal Cancer
CA19-9 for detecting recurrence of pancreatic cancer | Scientific Reports
The utility of the tumor markers CA15.3, CEA, CA-125 and CA19.9 in metastatic breast cancer | Breast Cancer Management
The prognostic value of serum CA 19-9 for patients with advanced lung adenocarcinoma | BMC Cancer | Full Text
